欢迎您！东篱公司
退出
-
申报数据库
-
立项数据库
-
成果数据库
-
项目获奖数据库
中文摘要：
随着肿瘤干细胞学说的不断发展,肿瘤干细胞标志物逐渐成为肿瘤研究的热点.CD44作为最常用的肿瘤干细胞标志物,近年来更是被广泛涉及.本文就以往关于CD44的研究成果,重点介绍CD44调控肿瘤发生发展机制研究的新进展.
英文摘要：
With the continuous development of the cancer stem cell theory,biomarkers for CSCs （Cancer stem cells） have gradually become the hot issues in tumor research.As the most commonly used CSCs biomarker,CD44 gains lots of attentions.This paper will review recent research about CD44 molecule and its powerful role in regulating tumor progenesis and progression.
同期刊论文项目
同项目期刊论文
MicroRNA-34a Targets Bcl-2 and Sensitizes Human Hepatocellular Carcinoma Cells to Sorafenib Treatmen
Altered Expression Levels of miRNAs in Serum as Sensitive Biomarkers for Early Diagnosis of Traumati
Myeloid-Specific Disruption of Recombination Signal Binding Protein J kappa Ameliorates Hepatic Fibr
The Significance of Notch1 Compared with Notch3 in High Metastasis and Poor Overall Survival in Hepa
Notch is the key factor in the process of fetal liver stem/progenitor cells differentiation into hep
The significance of Notch1 compared with Notch3 in high metastasis and poor overall survival inhepat
Downregulation of miR-200a Induces EMT Phenotypes and CSC-like Signatures through Targeting the beta
期刊信息
位置：